Gene Coexpression Network Characterizing Microenvironmental Heterogeneity and Intercellular Communication in Pancreatic Ductal Adenocarcinoma: Implications of Prognostic Significance and Therapeutic Target

Background Pancreatic ductal adenocarcinoma (PDAC) is characterized by intensive stromal involvement and heterogeneity. Pancreatic cancer cells interact with the surrounding tumor microenvironment (TME), leading to tumor development, unfavorable prognosis, and therapy resistance. Herein, we aim to clarify a gene network indicative of TME features and find a vulnerability for combating pancreatic cancer. Methods Single-cell RNA sequencing data processed by the Seurat package were used to retrieve cell component marker genes (CCMGs). The correlation networks/modules of CCMGs were determined by WGCNA. Neural network and risk score models were constructed for prognosis prediction. Cell–cell communication analysis was achieved by NATMI software. The effect of the ITGA2 inhibitor was evaluated in vivo by using a KrasG12D -driven murine pancreatic cancer model. Results WGCNA categorized CCMGs into eight gene coexpression networks. TME genes derived from the significant networks were able to stratify PDAC samples into two main TME subclasses with diverse prognoses. Furthermore, we generated a neural network model and risk score model that robustly predicted the prognosis and therapeutic outcomes. A functional enrichment analysis of hub genes governing gene networks revealed a crucial role of cell junction molecule–mediated intercellular communication in PDAC malignancy. The pharmacological inhibition of ITGA2 counteracts the cancer-promoting microenvironment and ameliorates pancreatic lesions in vivo. Conclusion By utilizing single-cell data and WGCNA to deconvolute the bulk transcriptome, we exploited novel PDAC prognosis–predicting strategies. Targeting the hub gene ITGA2 attenuated tumor development in a PDAC mouse model. These findings may provide novel insights into PDAC therapy.

• Publication year

  2022

• Venue

  Frontiers in Oncology

• Publication date

  2022-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fonc.2022.840474PMID 35719923PMCID 9198606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma

  2022cited by this paper
• Single-Cell Transcriptome Integration Analysis Reveals the Correlation Between Mesenchymal Stromal Cells and Fibroblasts

  2022cited by this paper
• USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade

  2021cited by this paper
• The small-molecule protein ligand interface stabiliser E7820 induces differential cell line specific responses of integrin α2 expression

  2021influential reference
• Single-cell RNA transcriptome reveals the intra-tumoral heterogeneity and regulators underlying tumor progression in metastatic pancreatic ductal adenocarcinoma

  2021cited by this paper
• Single cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk

  2021cited by this paper
• Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence

  2021cited by this paper
• Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

  2020cited by this paper
• Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment

  2020cited by this paper
• Pancreatic cancer

  2020cited by this paper
• Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer

  2020cited by this paper
• Laminin-511 and α6 integrins regulate the expression of CXCR4 to promote endothelial morphogenesis

  2020cited by this paper
• CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity

  2020cited by this paper
• Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma

  2020cited by this paper
• Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer

  2020cited by this paper
• Predicting cell-to-cell communication networks using NATMI

  2020influential reference
• Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis

  2020cited by this paper
• Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies

  2020cited by this paper
• EpCAM+CD73+ mark epithelial progenitor cells in postnatal human lung and is associated with pathogenesis of pulmonary disease including lung adenocarcinoma.

  2020cited by this paper
• Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry

  2019cited by this paper
• Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology

  2019cited by this paper
• Integrins as biomechanical sensors of the microenvironment

  2019cited by this paper
• Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts.

  2019cited by this paper
• Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity

  2019cited by this paper
• Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma

  2019cited by this paper
• Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway

  2019cited by this paper
• Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment

  2019cited by this paper
• Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis

  2019cited by this paper
• Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.

  2019cited by this paper
• The International Cancer Genome Consortium Data Portal

  2019cited by this paper
• Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

  2019cited by this paper
• Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

  2018cited by this paper
• Integrating single-cell transcriptomic data across different conditions, technologies, and species

  2018cited by this paper
• Spatial transcriptomic survey of human embryonic cerebral cortex by single-cell RNA-seq analysis

  2018cited by this paper
• Tumor Cell‐Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy

  2018cited by this paper
• Stromal biology and therapy in pancreatic cancer: ready for clinical translation?

  2018cited by this paper
• Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics

  2018cited by this paper
• Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

  2017cited by this paper
• Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.

  2017cited by this paper
• CancerSubtypes: an R/Bioconductor package for molecular cancer subtype identification, validation and visualization

  2017cited by this paper
• A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.

  2016cited by this paper
• The biology and function of fibroblasts in cancer

  2016cited by this paper
• Genomic analyses identify molecular subtypes of pancreatic cancer

  2016cited by this paper
• A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors

  2016cited by this paper
• Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes

  2016cited by this paper
• RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long‐term survival and reveals a role for ANGPTL4

  2016cited by this paper
• A draft network of ligand–receptor-mediated multicellular signalling in human

  2015cited by this paper
• Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

  2015cited by this paper
• Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

  2015cited by this paper
• TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

  2015cited by this paper
• Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

  2014cited by this paper
• Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer

  2013cited by this paper
• CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.

  2013cited by this paper
• Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy

  2011cited by this paper
• Phase I Study of E7820, an Oral Inhibitor of Integrin α-2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies

  2011cited by this paper
• Conducting Meta-Analyses in R with the metafor Package

  2010cited by this paper
• Integrins in cancer: biological implications and therapeutic opportunities

  2010cited by this paper
• A multipotent progenitor domain guides pancreatic organogenesis.

  2007cited by this paper
• An Angiogenesis Inhibitor E7820 Shows Broad-Spectrum Tumor Growth Inhibition in a Xenograft Model

  2004cited by this paper
• In silico dissection of cell-type-associated patterns of gene expression in prostate cancer.

  2004cited by this paper
• Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.

  2002cited by this paper
• Cdh5 Is Specifically Activated in Glioblastoma Stemlike Cells and Contributes to Vasculogenic Mimicry Induced by Hypoxia Neuro-onco Lo Gy Materials and Methods

  year unknowncited by this paper

• Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A single cell RNA-seq analysis.

  2025cites this paper
• Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition

  2025cites this paper
• Nutrient availability-driven changes in extracellular matrix biochemical and mechanical properties regulate pancreatic cancer cell biology

  2025cites this paper
• MIF as a potential diagnostic and prognostic biomarker for triple‐negative breast cancer that correlates with the polarization of M2 macrophages

  2024cites this paper
• Machine learning was used to predict risk factors for distant metastasis of pancreatic cancer and prognosis analysis

  2023cites this paper